Comparison
Turkesterone vs Ostarine
Non-hormonal natty-adjacent anabolic vs. the gold-standard gateway SARM.
Turkesterone
Phytoecdysteroid
Ostarine
Selective Androgen Receptor Modulator
Effectiveness Profile
At a Glance
| Turkesterone | Ostarine | |
|---|---|---|
| Type | Supplement | SARM |
| Legal status | OTC | Research |
| Half-life | 4–9 hours (extrapolated from ecdysterone) | ~24 hours |
| Preferred route | Oral | Oral |
| Dose frequency | twice-daily | once-daily |
| Beginner dose | 250–500 mg | 10–15 mg |
| Intermediate dose | 500–800 mg | 20–25 mg |
| Advanced dose | 1000–1500 mg | 25–30 mg |
| Cycle length | 8–12 wks | 8–12 wks |
| Bioavailability | 2% | 85% |
| Time to peak | 1.5h | 3h |
| Active duration | 8h | 24h |
| Storage | Room temperature, dry, sealed; avoid heat and humidity | Room temperature, away from light; liquid suspensions stable for months sealed |
| PCT required | No | Yes |
| Ancillaries required | No | Yes |
| Safe for women | Yes | Yes |
Verdict
Turkesterone wins for safety profile (non-hormonal, no suppression), zero PCT requirement, female-friendliness, and lowest risk of virilization or liver strain. It's the cleanest option for anyone wanting incremental gains or insurance during a bridge or natty recomp, especially when sourcing is tight or maximum conservatism is needed.
Ostarine wins for raw potency, consistently higher lean-mass retention in a deficit, clinical data backing, clear dose-response, and easier access to pharmaceutical-grade material on the grey market. Lean-preservation during aggressive cuts, contest prep, or any scenario demanding measurable effect size favors ostarine.
Pick A or B?
Pick Turkesterone if:
- The protocol requires a truly non-hormonal, suppression-free anabolic (e.g. between AAS or SARM cycles, or for users uninterested in running any HPTA-suppressing agent)
- A safety-first protocol is the main concern — no liver strain, no suppression, no PCT
- Female or risk-averse protocols where androgenic/virilization risks must be minimized
- A low-stakes natty recomp or bridge stack with creatine, ashwagandha, and other adaptogens
- Sourcing issues make reliable SARMs access questionable, or compliance risk is a factor
Pick Ostarine if:
- The goal is maximized lean-mass retention (or modest gain) in a caloric deficit, e.g. contest prep, mini cuts, or aggressive recomps
- A clear, dose-responsive effect is needed — user wants reliable, pharmacologically significant results
- Protocol is stacked with other SARMs or mild orals and non-trivial suppression (plus PCT) is acceptable
- Previous cycles with natty or plant-based anabolics were underwhelming in potency
- Prepared to manage mild suppression (short PCT if needed) and accept mild HDL drop